These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Direct evidence for the interaction of the nucleotide affinity analog 5'-p-fluorosulfonylbenzoyl adenosine with a platelet ADP receptor. Figures WR, Scearce LM, DeFeo P, Stewart G, Zhou F, Chen J, Daniel J, Colman RF, Colman RW. Blood; 1987 Sep 05; 70(3):796-803. PubMed ID: 3040157 [Abstract] [Full Text] [Related]
14. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin. Puri RN, Colman RF, Colman RW. Eur J Biochem; 1996 Mar 15; 236(3):862-70. PubMed ID: 8665907 [Abstract] [Full Text] [Related]
15. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Cusack NJ, Hourani SM. Br J Pharmacol; 1982 May 15; 76(1):221-7. PubMed ID: 6282375 [Abstract] [Full Text] [Related]
16. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor. Puri RN, Colman RW. J Cell Biochem; 1996 Apr 15; 61(1):97-108. PubMed ID: 8726359 [Abstract] [Full Text] [Related]
17. Proteolysis of the platelet surface: dissociation of shape change from aggregation. Kornecki E, Ehrlich YH, Hardwick DH, Lenox RH. Am J Physiol; 1986 Apr 15; 250(4 Pt 2):H550-7. PubMed ID: 3008579 [Abstract] [Full Text] [Related]